Neha Krishnamohan
Director/Board Member bij ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 55 565 $ op 31-03-2024
Profiel
Neha Krishnamohan is an Independent Director at Arcutis Biotherapeutics, Inc. She previously worked as a Vice President-Healthcare Investment Banking at The Goldman Sachs Group, Inc. from 2015 to 2021.
She also served as the CFO & Executive VP-Corporate Development at Kinnate Biopharma, Inc. from 2021 to 2024.
Ms. Krishnamohan completed her undergraduate degree at Duke University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-05-2023 | 5 607 ( 0.00% ) | 55 565 $ | 31-03-2024 | |
KINNATE BIOPHARMA, INC.
-.--% | 03-04-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Neha Krishnamohan
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 02-09-2022 |
Eerdere bekende functies van Neha Krishnamohan
| Bedrijven | Functie | Einde |
|---|---|---|
| KINNATE BIOPHARMA INC. | Director of Finance/CFO | 03-04-2024 |
| THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 01-05-2021 |
Opleiding van Neha Krishnamohan
| Duke University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| THE GOLDMAN SACHS GROUP, INC. | Finance |
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
